Abstract: A population of core/shell delivery particles, where the shell is made, at least in part, of a polymeric material that is the reaction product of a plant-based flour material crosslinking an isocyanate monomer, oligomer, or prepolymer. Related methods of making and using such compositions are described.

Abstract: Populations of benefit agent delivery particles are disclosed, the particles having a core and a shell encapsulating the core, the shell comprising certain multifunctional (meth)acrylate-based polymers, along with processes for making and uses of such compositions. The delivery particle has a core to polymer wall ratio by weight from about 96:4 to about 99.5 to 0.5 and a volume-weighted particle size from about 30 to about 50 microns. The compositions deliver core content with a desired delivery profile, such as fragrance delivery at desired touchpoints with higher efficiency. The delivery particle has high pay load, yet exhibits decreased benefit agent leakage, and provides a desired delivery profile.

Abstract: The invention describes a core shell microcapsule wherein the capsule shell is an interfacial copolymer formed of a modified polysaccharide free radical cross-linked with a multifunctional (meth)acrylate. The polysaccharide is hydrophobically modified with an adduct containing at least one unsaturated bond. The modification imparts hydrophobic character to the polysaccharide to act as an emulsifier, driving the modified polysaccharide to an oil-water interface of an encapsulation emulsion described, and creates an active bonding site for free-radical polymerization between the polysaccharide and multifunctional (meth)acrylate, thereby forming a microcapsule shell surrounding the core material.

Abstract: The invention describes a core shell microcapsule wherein the capsule shell is an interfacial copolymer formed of a modified polysaccharide free radical cross-linked with a multifunctional (meth)acrylate. The polysaccharide is hydrophobically modified with an adduct containing at least one unsaturated bond. The modification imparts hydrophobic character to the polysaccharide to act as an emulsifier, driving the modified polysaccharide to an oil-water interface of an encapsulation emulsion described, and creates an active bonding site for free-radical polymerization between the polysaccharide and multifunctional (meth)acrylate, thereby forming a microcapsule shell surrounding the core material.

Abstract: Compositions comprising a population of delivery particles comprising a core and a polymer wall surrounding the core are disclosed. The delivery particles are obtainable by a process comprising the steps of providing core materials and wall-forming materials, and encapsulating the core materials in the polymer wall. The wall-forming materials comprise structural monomers and a free radical initiating agent. The core materials comprise a benefit agent and a shielding agent. The benefit agent comprises aldehyde-containing benefit agents, ketone-containing benefit agents, or a combination thereof. The shielding agent is capable of complexing with the aldehyde-containing benefit agents, ketone-containing benefit agents, or a combination thereof. The population of core/shell delivery particles formed has a weight ratio of the core materials and the wall polymer of at least 95:5. Related articles, methods of making and using such compositions and articles are also disclosed.

Abstract: An improved delivery particle comprising a benefit agent core material and a shell encapsulating the core material is described, along with a process for forming such a delivery particle and articles of manufacture. The shell is the reaction product of an ATEC (amine-thiol ene) conjugate, which can be further reacted with one or more multifunctional (meth)acrylates or isocyanates, or both.

Abstract: A biodegradable delivery particle having a benefit agent containing core and a shell.

Abstract: A composition that comprises encapsulates, the encapsulates having a core that includes perfume characterized by an acid value of greater than 5.0 mg KOH/g of perfume, the encapsulates also including a shell that includes a (meth)acrylate material. Methods of making and using such compositions.

Abstract: Populations of benefit agent delivery particles are disclosed, the particles having a core and a polymer wall surrounding the core, the polymer wall comprising multifunctional (meth)acrylate-based polymers, along with processes for making and uses of such compositions, and articles made with such particles. The polymer wall comprises a (meth)acrylate polymer derived, at least in part, from wall monomers and at least one free radical initiator, wherein the wall monomers comprise at least 50%, by weight of the wall monomers, of (meth)acrylate monomers, wherein the at least one free radical initiator is present at a level of from about 15% to about 60%, by weight of the polymer wall, wherein the core comprises a benefit agent, wherein the core and the polymer wall are present in a weight ratio of from about 95:5 to about 99.5:0.5. The compositions deliver core content with a desired delivery profile.

Abstract: The present invention teaches a composition and process for irreversibly agglomerated charge stable core shell microcapsules, each microcapsule containing a benefit agent core material, which may be the same or different, the polymeric all or walls comprising one or more (meth)acrylate polymers, or optionally combinations with other polymers, along with a polyvalent cation. The capsules of the invention adhere better to surfaces, are more stable and are useful for delivery of benefit agents.

Abstract: A biodegradable delivery particle having a benefit agent containing core and a shell.

Abstract: A biodegradable delivery particle having a benefit agent containing core and a shell.

Abstract: An improved process of forming polyurea and chitosan microcapsules encapsulating a benefit agent is described. The process comprises forming a water phase comprising hydrolyzing chitosan in an acidic medium at a pH of 6.5 or less for an extended period and combining with a polyisocyanate. The reaction product of the hydrolyzed chitosan and polyisocyanate yields a microcapsule having improved release characteristics, with enhanced degradation characteristics in OECD test method 301B.

Abstract: An article of manufacture is described comprising the combination of an adjunct material and a delivery particle. The delivery particle comprising a benefit agent core material and a shell encapsulating the core material is described, along with a process for forming such a delivery particle and articles of manufacture. The shell is the reaction product of: i) an isocyanate or acid chloride or acrylate with ii) an amine-containing natural material having free amino moieties, and iii) an ?, ?-unsaturated compound, the ?, ?-unsaturated compound forming C—N covalent bonds with the amine moieties of the natural material. The delivery particle of the invention has improved release characteristics, with enhanced degradation characteristics in OECD test method 301B.

Abstract: An improved delivery particle comprising a benefit agent core material and a shell encapsulating the core material is described, along with a process for forming such a delivery particle and articles of manufacture. The shell is the reaction product of: i) an isocyanate or acid chloride or acrylate with ii) an amine-containing natural material having free amino moieties, and iii) an a, ? -unsaturated compound, the a, ? -unsaturated compound forming C-N covalent bonds with the amine moieties of the natural material. The delivery particle of the invention has improved release characteristics, with enhanced degradation characteristics in OECD test method 301B.

Abstract: Delivery particles encapsulating oily core materials have a shell material of hybrid poly acrylate and poly(beta-amino esters) (PAC/PBAE). The delivery particles may have a single shell of hybrid PAC/PBAE, dual shells including hybrid PAC/PBAE in an inner shell and PBAE in an outer shell crosslinked to the inner shell, or multiple shells including PAC in an inner shell, hybrid PAC/PBAE in a transitioning shell, and PBAE in an outer shell.

Abstract: The invention describes a core shell microcapsule wherein the capsule shell is an interfacial copolymer formed of a modified polysaccharide free radical cross-linked with a multifunctional (meth)acrylate. The polysaccharide is hydrophobically modified with an adduct containing at least one unsaturated bond. The modification imparts hydrophobic character to the polysaccharide to act as an emulsifier, driving the modified polysaccharide to an oil-water interface of an encapsulation emulsion described, and creates an active bonding site for free-radical polymerization between the polysaccharide and multifunctional (meth)acrylate, thereby forming a microcapsule shell surrounding the core material.

Abstract: An improved process of forming polyurea and chitosan microcapsules encapsulating a benefit agent is described. The process comprises forming a water phase comprising hydrolyzing chitosan in an acidic medium at a pH of 6.5 or less for an extended period and combining with a polyisocyanate. The reaction product of the hydrolyzed chitosan and polyisocyanate yields a microcapsule having improved release characteristics, with enhanced degradation characteristics in OECD test method 301B.

Abstract: The microcapsules and process of making describe a novel core shell microcapsule. The microcapsule incorporates a polysaccharide such as chitosan into the microcapsule wall forming the shell. The microcapsule shell is formed by dissolving chitosan into a material of structure wherein each R is independently selected from hydrogen, C1 to C8 alkyl, or a cyano group; and each y is independently an integer from 1 to 8, and reacting with a multifunctional (meth)acrylate.

Abstract: An improved process of making a benefit agent delivery particle and an improved microcapsule made by such process are disclosed. The process comprises the steps of providing a first composition of water phase 1, water phase 2, water phase 3 and an oil phase, where a water phase multifunctional (meth)acrylate monomer is selected to have a hydrophilicity index of least 25, or even at least 30 and the oil phase multifunctional (meth)acrylate monomer has a hydrophilicity index of 25 or less, or even 20 or less. The water phases comprise water, initiator, a water-soluble or dispersible amine(meth)acrylate or hydroxyl(meth)acrylate, a multifunctional (meth)acrylate and one water phase comprises water, carboxyalkyl(meth)acrylate and a base or quaternary ammonium acrylate. Water phases are combined to prereact the hydroxy- or amine(meth)acrylate and the multifunctional (meth)acrylate to form a multifunctional hydroxyl-amine(meth)acrylate pre-polymer.